MediPharm Labs Corp. (TSX:LABS)

Market Cap	27.62M +2.4%
Revenue (ttm)	46.10M +18.1%
Net Income	-8.03M
EPS	-0.02
Shares Out	424.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,166
Average Volume	174,578
Open	0.0650
Previous Close	0.0700
Day's Range	0.0650 - 0.0700
52-Week Range	0.0600 - 0.1200
Beta	0.78
RSI	50.38
Earnings Date	Mar 27, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 161
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.